IPO Announced
Agomab Therapeutics NV IPO
US$200m raised
Lodged 5 Feb 2026 · NASDAQ: AGMB · US$16.00 cash per share
Advisers
Lead managers
- Legal adviser
- Issuer
- Agomab Therapeutics NV
- Issuer based in
- Belgium
- Sector
- Biotech
- Tags
- Biotech, Drug Development, Pharma
Similar deals
- Latigo Biotherapeutics IPO Aug 2026 · US$346m · Biotech
- Suzhou Ribo Life Science Co. IPO Jan 2026 · Biotech
- Silence Therapeutics placement Aug 2026 · US$201m · Biotech
- Sensei Biotherapeutics placement Feb 2026 · US$200m · Biotech
- Processa Pharmaceuticals placement Jul 2026 · US$200m · Biotech
Sources
- 6 Feb 2026 Final IPO prospectus (424B4), Agomab Therapeutics NV sec.gov
- 9 Feb 2026 Goodwin Advises Agomab on Pricing of $200 Million Initial Public Offering goodwinlaw.com
- 9 Feb 2026 AgomAb Therapeutics $200 million IPO davispolk.com





